These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 25932140)
1. PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis. Liang Z; Jiang W; Ouyang M; Yang K Int J Clin Exp Med; 2015; 8(2):2097-107. PubMed ID: 25932140 [TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis. Zhang H; Dong P; Yang X; Liu Z Int J Clin Exp Med; 2014; 7(10):3777-88. PubMed ID: 25419432 [TBL] [Abstract][Full Text] [Related]
3. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population. Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255 [TBL] [Abstract][Full Text] [Related]
4. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis. Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536 [TBL] [Abstract][Full Text] [Related]
5. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility. Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513 [TBL] [Abstract][Full Text] [Related]
6. PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis. Xu X; Xie Y; Lin Y; Xu X; Zhu Y; Mao Y; Hu Z; Wu J; Chen H; Zheng X; Qin J; Xie L Exp Ther Med; 2012 Dec; 4(6):1127-1133. PubMed ID: 23226787 [TBL] [Abstract][Full Text] [Related]
7. Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis. Tabaei S; Omraninava M; Mehranfar S; Motallebnezhad M; Tabaee SS Biochem Genet; 2022 Oct; 60(5):1409-1445. PubMed ID: 35039979 [TBL] [Abstract][Full Text] [Related]
8. Factor XIII-A Val34Leu polymorphism might beassociated with myocardial infarction risk: an updated meta-analysis. Wang G; Zou Z; Ji X; Ni Q; Ma Z Int J Clin Exp Med; 2014; 7(12):5547-52. PubMed ID: 25664069 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss. Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335 [TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review. Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171 [No Abstract] [Full Text] [Related]
11. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. Anderson JL; Muhlestein JB; Habashi J; Carlquist JF; Bair TL; Elmer SP; Davis BP J Am Coll Cardiol; 1999 Nov; 34(6):1778-83. PubMed ID: 10577569 [TBL] [Abstract][Full Text] [Related]
12. CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review. Wang X; Yue K; Hao LR Int J Clin Exp Med; 2015; 8(8):11905-12. PubMed ID: 26550103 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis in the association between obesity and risk of thyroid cancer. Zhang W; Bai X; Ge H; Cui H; Wei Z; Han G Int J Clin Exp Med; 2014; 7(12):5268-74. PubMed ID: 25664030 [TBL] [Abstract][Full Text] [Related]
14. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Margaglione M; Cappucci G; Colaizzo D; Giuliani N; Vecchione G; Grandone E; Pennelli O; Di Minno G Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):152-6. PubMed ID: 9484978 [TBL] [Abstract][Full Text] [Related]
15. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis. Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216 [TBL] [Abstract][Full Text] [Related]
16. PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease. Lima LM; Carvalho Md; Fonseca Neto CP; Garcia JC; Sousa MO Arq Bras Cardiol; 2011 Dec; 97(6):462-389. PubMed ID: 22011808 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis. Huang Z; Tang W; Liang Z; Chen Q; Li M; Li Y; Lao S; Pan H; Huang L; Huang M; Hu X; Zhao J Reprod Sci; 2017 Nov; 24(11):1551-1560. PubMed ID: 28395596 [TBL] [Abstract][Full Text] [Related]
18. The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS. Zhang TT; Yuan L; Yang YM; Ren Y Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2326-31. PubMed ID: 25219833 [TBL] [Abstract][Full Text] [Related]
19. Association between dopamine receptor D2 TaqIA polymorphism and Parkinson disease risk: a meta-analysis. Song Y; Wang ZY; Jin YY; Guo J Int J Clin Exp Pathol; 2019; 12(9):3165-3170. PubMed ID: 31934160 [TBL] [Abstract][Full Text] [Related]
20. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population. Zheng H; Zhao Y Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]